FOG-001 in Locally Advanced or Metastatic Solid Tumors

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1, PHASE2

מצבים רפואיים

Cancer · Colorectal Cancer · Solid Tumor · Locally Advanced Solid Tumor · Metastatic Cancer · WNT Pathway · HCC · Desmoid · Microsatellite Stable Colorectal Cancer · Metastatic Castration-resistant Prostate Cancer · FAP · Endometrial Carcinoma · Prostate Cancer · Microsatellite Instability-High Colorectal Cancer · Adamantinomatous Craniopharyngioma

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

Mayo Clinic, Phoenix, Arizona, United States
Contact: Study coordinator (Mahesh Seetharam, MD) · 480-301-8000
Honor Health, Scottsdale, Arizona, United States
Contact: Study coordinator (Sunil Sharma, MD) · 480-323-1350
Arizona Cancer Center at University of Arizona, Tucson, Arizona, United States
Contact: Study coordinator (Aaron Scott, MD) · 520-694-2873
University of California, Los Angeles (UCLA), Los Angeles, California, United States
Contact: Study coordinator (Randy Hecht, MD) · 310-829-5471
Stanford Cancer Institute, Stanford University, Palo Alto, California, United States
Contact: Study coordinator (Nam Bui) · 650-498-6000
University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
Contact: Study coordinator (Varun Monga, MD) · 888-689-8273
Sarcoma Oncology Center, Santa Monica, California, United States
Contact: Study coordinator (Sant Chawla, MD) · 301-552-9999
University of Colorado, Aurora, Colorado, United States
Contact: Study coordinator (Breelyn Wilky, MD) · 305-243-1287
Yale University School of Medicine, New Haven, Connecticut, United States
Contact: Study coordinator (Michael Cecchini, MD) · 415-302-7807
Johns Hopkins University, Sibley Memorial Hospital, Washington D.C., District of Columbia, United States
Contact: Study coordinator (Mike J Pishvaian, MD/PhD) · 202-804-3343
Mayo Clinic, Jacksonville, Florida, United States
Contact: Study coordinator (Conor O'Donnell, MD) · 904-953-6870
Florida Cancer Specialists, Lake Mary, Florida, United States
Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
Contact: Study coordinator (Mike J Pishvaian, MD/PhD) · 410-955-8964
Contact: Study coordinator (Eric Christenson, MD) · 410-955-8964
Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Samuel Klempner, MD) · 617-724-4000
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Study coordinator (Candace Haddox, MD) · 617-632-3000
M Health Fairview University of Minnesota Medical Center, Minneapolis, Minnesota, United States
Contact: Study coordinator (Ajay Prakash, MD/PhD) · 612-273-8383
Mayo Clinic, Rochester, Minnesota, United States
Contact: Study coordinator (Hao Xie, MD) · 504-284-2511
Washington University School of Medicine, St Louis, Missouri, United States
Contact: Study coordinator (Moh'd Khushman, MD) · 314-362-9115
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Study coordinator (Rona Yaeger, MD) · 646-888-5109
Duke University, Durham, North Carolina, United States
Contact: Study coordinator (Niharika Mettu, MD) · 919-681-2954
University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland, Ohio, United States
Contact: Study coordinator (David Bajor, MD) · 216-765-9033
Cleveland Clinic, Cleveland, Ohio, United States
Contact: Study coordinator (Wen Wee Ma, MBBS) · 216-444-2200
Contact: Study coordinator (Dale Shepard, MD, PhD) · (216) 444-2200
Oregon Health and Science University, Portland, Oregon, United States
Contact: Study coordinator (Shivaani Kummar, MD) · 503-494-8534
University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Mark O'Hara, MD) · 215-662-4646
University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
Contact: Study coordinator (Dennis J Hsu, MD) · 412-623-1722
Sarah Cannon Research Institute, Nashville, Tennessee, United States
Contact: Study coordinator (Meredith S Pelster, MD) · 615-329-6862
Vanderbilt Ingram Cancer Center, Nashville, Tennessee, United States
Contact: Study coordinator (Kristen Ciombor, MD) · 615-322-3000
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Jordi Rodon Ahnert, MD/PhD) · 713-792-5603
South Texas Accelerated Research Therapeutics, LLC, San Antonio, Texas, United States
Contact: Study coordinator (Kyriakos Papadopoulos, MD) · 210-593-5255
University of Virginia, Charlottesville, Virginia, United States
Contact: Study coordinator (Ludimila Cavalcante, MD) · 434-358-8780
University of Wisconsin, Carbone Cancer Center, Madison, Wisconsin, United States
Contact: Study coordinator (Jeremy Kratz, MD) · 608-263-1300
Integrated Clinical Oncology Network (ICON), South Brisbane, Queensland, Australia
Contact: Study coordinator (Vladimir Andelkovic, MD) · +61755198211
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Contact: Study coordinator (Jeremy Lewin, MD) · +61385595000

מובילי המחקר

Jorge Ramos, DO
Study Chair
Parabilis Medicines, Inc.

צפייה במקור ב־ClinicalTrials.gov פנייה לחוקר (אימייל)